Company Filing History:
1 out of 11 
1 out of 1,979 
1 out of 1,387 
Years Active: 1991-2005
Title: The Innovations of William P. Arend
Introduction
William P. Arend is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of biochemistry, particularly in the development of interleukin-1 inhibitors. With a total of three patents to his name, Arend's work has had a substantial impact on medical treatments.
Latest Patents
Arend's latest patents include groundbreaking research on nucleic acids encoding interleukin-1 inhibitors and processes for preparing these inhibitors. One of his patents discloses compounds with the general formula R—X—R, where R and R are biologically active groups, at least one of which is polypeptidic. The non-peptidic polymeric group X plays a crucial role in the functionality of these compounds. Additionally, his patents cover site selectively modified interleukin-1 receptor antagonists and 30 kDa TNF inhibitors, which are essential for advancing therapeutic methods.
Career Highlights
Throughout his career, Arend has worked with various companies, including Synergen, Inc. His innovative research has led to the development of compositions and methods for treating patients with interleukin-1 inhibitors. His work is recognized for its potential to improve treatment outcomes for various inflammatory conditions.
Collaborations
Arend has collaborated with notable professionals in his field, including Charles H. Hannum and Robert C. Thompson. These collaborations have further enhanced the quality and impact of his research.
Conclusion
William P. Arend's contributions to the field of biochemistry and his innovative patents have paved the way for advancements in medical treatments. His work continues to influence the development of therapies aimed at combating inflammatory diseases.